SHSE:600196 (China)  
Shanghai Fosun Pharmaceutical (Group) Co Ltd logo

Shanghai Fosun Pharmaceutical (Group) Co Ltd

¥ 42.78 (-0.93%) Aug 18
P/E:
25.41
P/B:
2.89
Market Cap:
¥ 104.51B ($ 15.39B)
Enterprise V:
¥ 117.15B ($ 17.25B)
Volume:
15.53M
Avg Vol (2M):
38.43M
Also Trade In:
Volume:
15.53M
Market Cap ¥:
104.51B
Market Cap $:
15.39B
PE Ratio:
25.41
Avg Vol (2-Month):
38.43M
Enterprise Value ¥:
117.15B
Enterprise Value $:
17.25B
PB Ratio:
2.89
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download Tutorials

Business Description

Shanghai Fosun Pharmaceutical (Group) Co Ltd
NAICS : 325412
No. 1289 Yishan Road, Building A, Fosun Technology Park, Shanghai, CHN, 200233
Description
Shanghai Fosun Pharmaceutical (Group) Co Ltd is a specialty and generic drug manufacturing company. Shanghai Fosun maintains five business segments, including Pharmaceutical manufacturing, Healthcare Services, Medical devices and medical diagnosis, Pharmaceutical distribution and retail, and Other business operations. Most of the company's revenue is generated by its Pharmaceutical manufacturing segment. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil ¥) 41,330.906
EPS (TTM) (¥) 1.7
Beta 1.41
Volatility % 48.57
14-Day RSI 43.31
14-Day ATR (¥) 1.451282
20-Day SMA (¥) 44.509
12-1 Month Momentum % -29
52-Week Range (¥) 37.18 - 71.74
Shares Outstanding (Mil) 2,669.66

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Shanghai Fosun Pharmaceutical (Group) Co Ltd Filings

Document Form Filing Date
No Filing Data